Rebecca Jones

About Rebecca Jones

Strategic and results-driven Program Management Professional with 15+ years leading cross-functional drug development teams from early research through regulatory approval and global launch. Focused on action, with deep expertise in overseeing complex and high-impact programs. Exceptional at translating scientific, clinical, regulatory, and CMC complexity into clear, actionable strategy that drives alignment, accelerates decision-making, and sustains progress in fast-paced environments. Recognized for consistently delivering on corporate objectives, often on timelines faster than industry standard. Known for building trust across diverse stakeholders, mentoring & empowering team members, and establishing nimble governance frameworks.

Experience

1. Senior Director Program Management

   Novavax

   Sep 2023 — Present

   Program Team Lead: COVID-19 Vaccine (Commercial Product)Program Team Lead: COVID Influenza Combo (CIC)(Phase 3)Program Team Lead: Trivalent Nanoparticle Influenza (Phase 3)• Drive program goals and strategy, decision making, risk management, prioritization, and collaboration – at the working team level and as a thought partner with executive leaders. • Direct end-to-end integrated project plans for cross functional teams and ensure seamless execution in very fast-paced and dynamic drug development programs.• Effective communicator that ensures visibility and reporting on program deliverables, risks, and status at all levels of the organization. • Pioneered the cutting-edge strain change strategy to be market competitive & provide a protein-based COVID-19 vaccine option.• Lead weekly Program Teams. Communicate regularly with Executive Team. • Collaborate regularly across all functions including R&D, Preclinical, Clinical Development, Technical Operations, Regulatory, Quality, Supply Chain, Commercial.Accomplishments:• Developed program management best practices, standards and governance processes that are applied to all Novavax programs. • Ensured on-time regulatory submissions and season launch for COVID strain change to enable a protein-based vaccine option for the public in markets worldwide.• Launched Strain Selection Committee, which monitors COVID and Flu strain development, world-wide strain emergence, industry trends, and government policy decisions. Facilitate committee; drive strategy and decision making.• Oversaw development of corporate processes for COVID annual strain change and timelines. • Performance driven promotions twice in 2 years: Associate Director to Director to Senior Director.

Education

• Colorado State University

  BS, Biochemistry

Skills

• Gmp
• Quality System
• Filtration
• Program Management
• Quick Changeover
• Lifesciences
• Purification
• Capa
• Operational Excellence
• Resource Management
• Chromatography
• Pharmaceutical Industry
• Sop
• Technical Project Leadership
• Fda
• Technology Transfer
• Lean Manufacturing
• Trackwise
• Validation
• Cell Culture
• Hplc
• Decisiveness
• Aseptic Technique
• Microbiology
• Biotechnology
• Change Control
• Aseptic Processing
• Glp
• Cross-Functional Team Leadership
• Manufacturing